U.S. Basic Materials Stock News

Oscar Health recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando, where its CFO reiterated the 2026 outlook and addressed policy and capital concerns. Management also highlighted stronger-than-expected enrollment of 3.4 million members and extensive reinsurance support, underscoring how scale and risk-sharing underpin the business model. Next, we’ll explore how this reaffirmed outlook and higher enrollment may influence Oscar Health’s investment...

In February 2026, Capital Southwest Corporation’s board declared past monthly regular dividends of US$0.1934 per share for April, May, and June 2026, with corresponding ex-dividend, record, and payment dates for each month. The company also announced a supplemental dividend of US$0.06 per share for the June 2026 quarter, underscoring its emphasis on shareholder cash returns alongside regular distributions. With the newly declared regular and supplemental dividends highlighting cash returns,...

AnaptysBio (ANAB) has drawn fresh attention after reporting a fourth quarter earnings swing to net income of US$49.61 million, supported by collaboration revenues and milestone payments tied to cancer drug Jemperli. See our latest analysis for AnaptysBio. The strong earnings swing and Jemperli related revenues arrive after a sharp rerating in the shares. The current US$55.41 price follows a 24.49% 90 day share price return and a 1 year total shareholder return of 239.11%, suggesting momentum...

In February 2026, Paychex announced new AI-driven enhancements across its Paycor and Paychex Flex platforms, including automated scheduling, time and attendance, and time-off management tools designed to streamline workforce management for small and midsized businesses. These AI features, such as human-in-the-loop smart scheduling and agent-assisted time-off approvals, reflect Paychex’s push to bring enterprise-grade automation and transparency to everyday HR tasks. Next, we’ll examine how...

In early March 2026, Bank of America Corporation issued a series of new senior unsecured notes across multiple maturities while simultaneously moving to redeem existing US dollar, euro, and yen senior notes ahead of their 2027 maturities, reshaping its funding profile. This combination of fresh fixed‑income offerings and early redemptions highlights how the bank is actively managing its liability mix and interest costs against a backdrop of sector risks and geopolitical uncertainty. We’ll...

Why Quest Diagnostics Stock Is on Investors’ Radar Quest Diagnostics (DGX) is back in focus after recent trading, with the share price last closing at $199.21. Investors are weighing that level against the company’s earnings profile, cash generation, and overall business stability. See our latest analysis for Quest Diagnostics. While the 1-day share price return of 2.34% and 7-day share price return of 5.99% have cooled sentiment a bit, the 30-day and year-to-date share price returns of 4.46%...

In late February and early March 2026, analysts including Citi, Raymond James, and Barclays turned more cautious on American Homes 4 Rent, citing softer rental demand, elevated new supply, and rising concessions across single-family and multifamily markets. At Citi’s Miami Global Property CEO Conference 2026, American Homes 4 Rent outlined its response with a new US$500 million share repurchase authorization and plans to develop about 1,900 homes in 2026 while closely tracking legislative...

In early March 2026, Arcutis Biotherapeutics reported strong 2025 results with revenue of US$376.07 million, a swing to quarterly profitability, raised its 2026 net product revenue guidance to US$480 million–US$495 million, advanced its ARQ-234 atopic dermatitis program into a Phase 1a/1b trial, and elevated Mas Matsuda to executive vice president, chief legal officer, and corporate secretary. Together, these developments point to a company moving from pure development-stage biotech toward a...

Repligen (RGEN) has been under pressure after a weaker February jobs report hit healthcare stocks, even as the company recently reported quarterly and full year 2025 results that showed positive revenue and net income figures. See our latest analysis for Repligen. At a share price of US$119.99, Repligen has seen a 1 day share price return of 4.03% decline, a 30 day share price return of 15.61% decline, and a 1 year total shareholder return of 22.94% decline. This suggests momentum has been...

Graham Holdings Company recently reported its fourth-quarter and full-year 2025 results, with quarterly sales edging up to US$1,251.02 million while net income and earnings per share from continuing operations fell sharply year over year, alongside US$10.10 million of impairment charges on intangible and other long-lived assets. The company’s decision to maintain a regular quarterly dividend of US$1.88 per share, even as full-year net income dropped significantly, highlights a continued...

Lindsay (LNN) has rolled out two new road safety products, the Road Runner Truck Mounted Attenuator and the AlphaGuard channelizing device, giving investors fresh information on its infrastructure focused portfolio. See our latest analysis for Lindsay. The recent product launches come as Lindsay's 90 day share price return of 9.67% and year to date share price return of 6.97% contrast with a 1 year total shareholder return of 0.72% decline, suggesting shorter term momentum has picked up after...

CNO Financial Group recently expanded its retirement offerings through Bankers Life’s Enhanced Death Benefit Rider for its Guaranteed Lifetime Income Annuity products, while its survey of Americans aged 50 to 85 highlighted growing concerns about inflation, longevity risk, and potential Social Security changes. Together, the new rider and survey insights underline how middle-income retirees are increasingly focused on balancing guaranteed income with the ability to leave a financial legacy...

Quarterly earnings and dividend catch investors’ attention Smith & Wesson Brands (SWBI) recently reported third quarter results alongside a fresh dividend announcement. This gives investors new data on both operating performance and direct cash returns. For the quarter ended January 31, 2026, sales were US$135.71 million compared with US$115.89 million a year earlier, while net income was US$3.75 million versus US$2.10 million. See our latest analysis for Smith & Wesson Brands. The earnings...

In February 2026, RLI Corp. completed a US$299.93 million fixed-rate senior unsecured notes offering, issuing 5.375% callable notes due June 1, 2036, alongside an amended and restated credit agreement with PNC Bank that extended maturity and expanded committed capacity. This combination of long-dated debt and enhanced bank financing reshapes RLI’s capital structure, potentially giving management more room to fund growth projects and manage liquidity across insurance cycles. Next, we’ll...

What JPMorgan Chase’s Recent Share Performance Signals for Investors JPMorgan Chase (JPM) shares have softened recently, with a 1 day return of a 1.39% decline and a roughly 10% decline over the past month. This has prompted investors to reassess what the current price may already reflect. See our latest analysis for JPMorgan Chase. The recent 1 month share price return of a 10.21% decline, alongside an 11.06% share price decline year to date from the latest share price of US$289.48,...

If you are wondering whether Interface is still good value after a strong run, this article will walk through what the current share price might be implying about the company. The stock closed at US$28.14, with a 10.6% decline over the last 7 days and an 18.7% decline over the last 30 days, while the 1 year return sits at 54.5% and the 5 year return at 102.5%. Recent news coverage around Interface has largely focused on its position in commercial flooring and modular carpet, along with how...

What Albertsons Companies (ACI) investors are reacting to now Albertsons Companies (ACI) is back on investor radars after recent trading, with the share price around $17.77 and returns mixed across time frames, including a decline over the past year and a gain over the past 3 months. See our latest analysis for Albertsons Companies. The latest move to around $17.77 follows a 1-day share price return of 2.72%, set against a 3-month share price return of 3.55% and a 1-year total shareholder...

Earlier this week, Duke Energy Corporation established a US$6.00 billion at-the-market common stock offering and related forward sale agreements to raise equity capital for grid and generation investments. The program gives Duke Energy unusual flexibility to time share issuance and manage dilution as it funds renewable projects and infrastructure upgrades. We’ll now examine how this sizeable at-the-market equity program, aimed at funding renewables and grid upgrades, reshapes Duke Energy’s...

Nurix Therapeutics recently amended its equity distribution agreement to allow sales of up to US$413.65 million of common stock through Piper Sandler under its existing shelf registration. This expanded at-the-market facility gives Nurix added funding flexibility, potentially affecting how investors assess its balance between capital needs and ownership dilution. We will now examine how this enlarged at-the-market capacity shapes Nurix’s investment narrative, particularly around funding...

The weak U.S. February jobs report, which showed an unexpected drop in employment, weighed on financial stocks as investors reassessed risk. StepStone Group (STEP) saw its share price move lower along with broader sector pressure. See our latest analysis for StepStone Group. At a last close of US$45.66, StepStone Group’s 1 day share price return of a 4.12% decline followed a weak jobs report, extending a 30 day share price return of a 26.86% decline and a year to date share price return of a...

Conference spotlight and why investors care Nextpower (NXT) is set to present at the Jefferies Power, Utilities, & Clean Energy Conference in New York on March 4, 2026. The presentation will give investors a closer look at its solar tracker business. This conference appearance follows a 46.5% rise in the share price over the past six months and years of 25% compound annual sales growth. These factors have contributed to raising Nextpower's profile on many investors' watchlists. See our latest...

Why T. Rowe Price Group is on investors’ radar T. Rowe Price Group (TROW) shares have been under pressure recently, with the stock showing negative returns over the past month, past 3 months and year to date, drawing attention to how the asset manager is currently valued. See our latest analysis for T. Rowe Price Group. At a share price of $90.40, T. Rowe Price Group has seen pressure build, with a 1 day share price return of 1.78% decline and a 90 day share price return of 13.51% decline...

In February 2026, Atlas Energy Solutions reported fourth-quarter 2025 revenue of US$249.43 million and a quarterly net loss of US$22.24 million, while full-year 2025 revenue rose to US$1.10 billion alongside a full-year net loss of US$50.30 million versus a profit the year before. Despite swinging to losses, Atlas highlighted record utilization of its Dune Express system and new initiatives in power generation aimed at broadening its revenue base beyond traditional sand and logistics. We’ll...

Savara (SVRA) is in focus after the FDA’s Day 74 Letter for MOLBREEVI indicated that no Advisory Committee meeting is planned, while parallel filings in Europe and the U.K. push its autoimmune PAP program onto a broader regulatory track. See our latest analysis for Savara. Despite the FDA letter and ongoing regulatory progress, Savara’s 1 day share price return of a 4.01% decline and 7 day share price return of a 12.46% decline point to cooling short term momentum. At the same time, the 1...